1. Home
  2. ACCL vs VTGN Comparison

ACCL vs VTGN Comparison

Compare ACCL & VTGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Acco Group Holdings Limited Ordinary Shares

ACCL

Acco Group Holdings Limited Ordinary Shares

N/A

Current Price

$2.29

Market Cap

26.9M

ML Signal

N/A

Logo VistaGen Therapeutics Inc.

VTGN

VistaGen Therapeutics Inc.

HOLD

Current Price

$0.25

Market Cap

25.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ACCL
VTGN
Founded
2009
1998
Country
Hong Kong
United States
Employees
22
N/A
Industry
Professional Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
26.9M
25.3M
IPO Year
N/A
2014

Fundamental Metrics

Financial Performance
Metric
ACCL
VTGN
Price
$2.29
$0.25
Analyst Decision
Hold
Analyst Count
0
3
Target Price
N/A
$0.90
AVG Volume (30 Days)
24.6K
1.2M
Earning Date
05-20-2026
06-16-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$124.49
Revenue Next Year
N/A
$353.99
P/E Ratio
$17.13
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.23
$0.20
52 Week High
$5.00
$5.14

Technical Indicators

Market Signals
Indicator
ACCL
VTGN
Relative Strength Index (RSI) 79.16 38.66
Support Level $1.31 $0.22
Resistance Level $2.34 $0.65
Average True Range (ATR) 0.11 0.01
MACD 0.02 0.02
Stochastic Oscillator 88.04 94.74

Price Performance

Historical Comparison
ACCL
VTGN

About ACCL Acco Group Holdings Limited Ordinary Shares

Acco Group Holdings Ltd is a holding company. Through its Operating Subsidiaries, it is a multi-disciplinary, IT-driven corporate service provider with a presence in Hong Kong and Singapore. Under the Accolade brand, it specializes in offering corporate secretarial services and accounting services in Hong Kong, as well as intellectual properties (IP) registration services in Singapore. Leveraging developed IT solutions, It provides comprehensive, reliable and professional support to its clients, enabling them to focus on their core business activities while it manages and handles their corporate compliance needs. Its clientele ranges from individual clients, small and medium-sized enterprises to multinational corporations, reflecting its ability to cater to diverse business needs.

About VTGN VistaGen Therapeutics Inc.

Vistagen Therapeutics Inc is a late clinical-stage therapeutics company focused on developing and commercializing medicines for patients with social anxiety disorder, depression, menopausal hot flashes, psychomotor impairment due to mental fatigue, and cancer cachexia. The company is engaged in developing intranasal product candidates called pherines, which leverage the understanding of nose-to-brain neurocircuitry. Vistagen's pherine pipeline consists of various product candidates like: Fasedienol, Itruvone, PH15, Refisolone, and PH284, which are being developed to provide treatment for a variety of disorders. Additionally, it is seeking potential partners for the further clinical development and commercialization of an oral drug candidate, AV-101, to treat certain neurological disorders.

Share on Social Networks: